Clinical trials
Transplant clinical trials
Below are recruiting transplant clinical trials, each written for real people, not researchers. We’re tracking 1,496 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05973734Enrolling by invitationPhase 1
Islet transplant with immune cells to treat type 1 diabetes
This Phase 1 study tests a new immune-system strategy around islet transplantation (or donor bone marrow therapy) to improve control of type 1 diabetes and reduce dangerous low blood sugar. It mainly aims to see if the approach is safe and helpful in people with long-standing, difficult-to-manage diabetes.
Palo Alto, CaliforniaAges 18–70 - NCT05968833Recruiting
Parent peer support for kids after kidney transplant
This program pairs parents with other parents who have been through a pediatric kidney transplant. It may help you cope and adjust by sharing experiences and support through WhatsApp.
Toronto, OntarioAges 18–75 - NCT05968807Recruiting
WhatsApp support for parents after a child’s organ transplant
This program pairs parents together using WhatsApp—experienced parents (mentors) and newer parents (mentees). It aims to help parents cope and adjust after a child’s solid organ transplant.
Toronto, OntarioAges 18–75 - NCT06493526RecruitingPhase 4
Mycophenolate therapy for kidney transplant patients with no DQ mismatch
This trial tests a mycophenolate-based therapy for kidney transplant recipients who have no HLA-DQ mismatch. If you had your first kidney transplant 3-12 months ago without DQ mismatch and are on standard immunosuppressants, you may qualify.
Edegem, AntwerpAges 18 years+ - NCT06478017RecruitingPhase 2
Belatacept for heart transplant patients
This study tests whether a drug called belatacept can safely help your body accept a new heart without rejecting it, and may reduce the need for other strong immune-suppressing medicines. If you are getting a heart transplant for the first time and have certain immune markers, this trial may be an option for you.
Los Angeles, CaliforniaAges 18–71 - NCT07047183RecruitingPhase 2
A study of venetoclax and azacitidine before stem cell transplant for MDS
This trial tests a combination of two drugs (venetoclax and azacitidine) given before a stem cell transplant to see if it improves outcomes for people with a certain type of myelodysplastic syndromes (MDS) that is higher risk. If you have higher-risk MDS and are planning a stem cell transplant, this may be an option.
Changchun, JilinAges 18 years+ - NCT06262451Enrolling by invitation
Fecal transplant national registry study
This study creates a registry for people who receive fecal microbiota transplants (FMT) to track long-term safety and outcomes. It may help researchers understand how this treatment works over time.
San Francisco, CaliforniaAges Any age - NCT06314230Recruiting
Genomics of chronic kidney transplant failure study
This study looks at how genes affect long-term kidney transplant health. It aims to understand why some transplanted kidneys fail over time, and may help personalize care for transplant recipients.
Westmead, New South WalesAges 18–75 - NCT06093867Recruiting
Tracking lung health after stem cell transplant
This study follows people getting a stem cell transplant to watch for lung problems, like infections or other lung diseases, that can happen after the transplant. The goal is to catch these issues early.
Bethesda, MarylandAges 5–70 - NCT07530913Enrolling by invitation
Digital Rehabilitation Platform for Liver Transplant Patients
This study tests a smartphone or tablet-based exercise program designed to help people recovering from living donor liver transplant surgery. The goal is to see if using guided exercises on a digital device at home improves recovery and quality of life after transplant.
SeoulAges 20–65 - NCT06712108Recruiting
Double cord blood transplant for blood cancers
This trial tests using a double (two units) umbilical cord blood transplant as a first-time donor stem cell transplant for adults with certain blood cancers or bone marrow failure diseases. It aims to see if this approach is effective and safe for patients who need a stem cell transplant but lack a fully matched donor.
Jeonju, Jeonlabuk-doAges 19 years+ - NCT07061444Recruiting
Breathing muscle training for stem cell transplant patients
This trial tests different breathing exercises to help people recover after a stem cell transplant. It looks at whether these exercises can improve strength and recovery.
Istanbul, ZeytinburnuAges 18–65 - NCT07102550RecruitingPhase 2
Amniotic tissue for bile duct repair in living donor liver transplant
This trial tests whether using amniotic tissue during bile duct connection surgery can improve outcomes for people receiving a liver transplant from a living donor.
Cleveland, OhioAges 18 years+ - NCT06377540RecruitingPhase 2
Pembrolizumab plus BEAM with stem cell transplant for Hodgkin lymphoma
This trial tests whether adding the immunotherapy drug pembrolizumab (Keytruda) to the standard BEAM chemotherapy before a stem cell transplant can help people with relapsed Hodgkin lymphoma. It's for patients who are eligible for a transplant and have stable organ function.
Minneapolis, MinnesotaAges 18 years+ - NCT06734013Recruiting
Genetic testing to help diagnose liver transplant rejection
This study looks at whether genetic testing of a tissue sample (biopsy) can help doctors more accurately diagnose rejection after a liver transplant. It is for people who have already been diagnosed with rejection and have a stored tissue sample available.
BolognaAges 18 years+ - NCT07574398Recruiting
Growth and Development Study After Infant Liver Transplant
This study tracks how babies grow and develop after receiving a liver transplant. Researchers want to understand how transplantation affects children's physical growth and overall development in early infancy.
Shanghai, Shanghai MunicipalityAges Up to 1 year - NCT06533852RecruitingPhase 3
Fecal transplant trial for liver cirrhosis complications
This study tests whether stool from healthy donors can help people with advanced liver disease (cirrhosis) who have had complications like fluid buildup. You would receive the transplant through a colonoscopy or enema.
BarcelonaAges 18 years+ - NCT06406179Recruiting
Blood test for donor DNA in kidney transplant care
This trial is testing whether a simple blood test that looks for donor DNA can help doctors take better care of kidney transplant patients. It may help detect early signs of rejection and guide treatment decisions.
ParisAges 18 years+ - NCT06743477Recruiting
Super transplant for severe thalassemia in children
This trial tests a new type of transplant (called 'super transplantation') for children with severe thalassemia. It aims to help those who cannot get a fully matched donor or have chosen not to have standard treatments.
Kunming, YunnanAges 7–12 - NCT07570771Recruiting
Dialysis duration effects on bladder function in transplant candidates
This study examines how long you've been on dialysis and how much urine you still produce might affect your bladder's ability to hold and stretch after a kidney transplant. Understanding this helps doctors predict how well your bladder will work after you receive a new kidney.
Karachi, SindhAges 18–65 - NCT06749990Recruiting
Alcohol relapse risk after liver transplant
This study looks at why some people with alcohol-related liver disease start drinking again after a liver transplant. It aims to find factors that increase or decrease that risk.
BolognaAges 18 years+ - NCT07532382Recruiting
Personalized Stories to Help Young Kidney Transplant Recipients
This study uses personalized storytelling to help children aged 5–12 who have received a kidney transplant. Researchers believe that hearing stories from other transplant recipients might help children understand their condition better and cope with their new life after transplant.
Paris, Île-de-France RegionAges 5–12 - NCT06759831Recruiting
Clinical outcomes of living and deceased donor kidney transplants
This study looks at how well kidney transplants work from both living and deceased donors. It may help doctors better understand long-term outcomes for people who get a new kidney.
Bologna, BOAges 18 years+ - NCT06280950RecruitingPhase 2
Reducing immune-suppressing drugs after liver transplant with everolimus
This study tests if adding everolimus can allow liver transplant recipients to safely reduce their usual immune-suppressing medicines. It aims to protect kidney function while preventing organ rejection.
Phoenix, ArizonaAges 18 years+
Hear when a new Transplant trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for transplant?
- Yes. Clin2 currently lists 1,496 recruiting transplant studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a transplant trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a transplant trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.